Asciminib, sold under the brand name Scemblix, is a medication used to treat Philadelphia chromosome-positive chronic myeloid leukemia. It is a protein kinase inhibitor. Reference standards of Asciminib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Asciminib - API Standards [catalogue_number] => PA 01 3630000 [category_ids] => ,76,78,70,82, [chemical_name] => [weight] => 449.84 [form] => C20H18ClF2N5O3 [cas] => 1492952-76-7 [pslug] => 1492952-76-7-asciminib-api-pa013630000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 01 3630000
CAS :
Molecular Formula : C20H18ClF2N5O3
Molecular Weight : 449.84
stdClass Object ( [pname] => (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-N-nitroso-5-(1H-pyrazol-3-yl)nicotinamide [catalogue_number] => PA 01 3631000 [category_ids] => ,76,78,70,82,162, [chemical_name] => [weight] => 478.84 [form] => C20H17ClF2N6O4 [cas] => NA [pslug] => r-n-4-chlorodifluoromethoxy-phenyl-6-3-hydroxypyrrolidin-1-yl-n-nitroso-5-1h-pyrazol-3-yl-nicotinamide-pa013631000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 01 3631000
Molecular Formula : C20H17ClF2N6O4
Molecular Weight : 478.84
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....